ICD-10 Code L01.1: Impetiginization of other dermatoses

Key Takeaways

ICD-10 Code L01.1 describes impetiginization of other dermatoses: secondary bacterial infection superimposed on a pre-existing skin condition such as atopic dermatitis.

L01.1 is a billable, specific ICD-10-CM code valid for 2026 reimbursement. L01.0 (Impetigo) is non-billable and must not be used instead.

When impetiginization occurs alongside a documented underlying dermatosis, both codes should be reported: L01.1 plus the code for the primary skin condition (e.g., L20 for atopic dermatitis).

Pabau’s structured client record and claims management workflows help dermatology teams capture dual diagnoses accurately and reduce claim errors for complex skin infection encounters.

ICD-10 Code L01.1 (Impetiginization of other dermatoses) is a billable, specific ICD-10-CM diagnosis code valid for the 2026 coding year. It sits within the L00-L08 block (Infections of the skin and subcutaneous tissue) and describes secondary bacterial infection that develops on top of a pre-existing, documented skin condition rather than presenting as primary impetigo in otherwise healthy skin.

This guide covers the clinical definition of L01.1, its position within the L01 code family, dual-coding rules for the underlying dermatosis, documentation requirements, and reimbursement considerations for dermatology and primary care billing teams.

Impetiginization of other dermatoses: clinical overview

Impetiginization refers to the secondary colonization and infection of damaged or inflamed skin by bacteria, most commonly Staphylococcus aureus or Streptococcus pyogenes. Unlike primary impetigo, which arises on intact or minor-trauma skin, impetiginization requires a pre-existing dermatosis that has compromised the skin barrier.

The most common underlying conditions include atopic dermatitis (eczema), seborrheic dermatitis, contact dermatitis, psoriasis, scabies, and insect bites. Scratching, excoriation, and chronic inflammation weaken the barrier and create an entry point for bacterial colonization. Using structured skin assessment tools at each visit helps clinicians detect the early signs of secondary infection before they progress.

Clinically, impetiginization presents as honey-colored crusting, pustules, or erosions overlying an existing rash. The distinction from primary impetigo matters both clinically and for coding: the treatment approach, antibiotic stewardship decisions, and documentation all differ when the infection is secondary to a chronic skin condition.

ICD-10 Code L01.1 in the L01 code family

The L01 code family covers impetigo in all its forms. Understanding where L01.1 sits within this hierarchy is essential for selecting the right code and avoiding claim errors.

L01.0 and its parent L01 are non-billable. Coders must always select a more specific code. L01.1 is the single billable code under L01 that captures secondary infection on a pre-existing skin condition. It has no further subcodes; L01.1 itself is the terminal, billable code.

L01.1 vs L01.00: choosing the right impetigo code

The choice between L01.1 and the L01.00-L01.09 subcodes comes down to one question: does the patient have a documented, pre-existing dermatosis that the bacterial infection has overlaid?

• Use L01.1 when the chart documents an underlying skin condition (atopic dermatitis, psoriasis, seborrheic dermatitis, scabies, contact dermatitis) and the bacterial infection has developed on that compromised skin. The dermatosis is the primary problem; the infection is a complication.
• Use L01.01 (non-bullous) or L01.03 (bullous) when the impetigo arises in skin without a documented pre-existing dermatosis. This is primary impetigo in otherwise normal skin.
• Use L01.00 only when the type of impetigo (bullous vs. non-bullous) is genuinely unspecified in the documentation. It should not be a default when the chart simply omits the detail.

The clinical and coding distinction matters for audit purposes. A patient with a longstanding atopic dermatitis diagnosis whose chart now notes “infected eczema” warrants L01.1 alongside the atopic dermatitis code, not a standalone L01.00. Coders unfamiliar with secondary ICD-10 diagnostic coding conventions sometimes default to the less-specific code, creating a mismatch between clinical and billing records.

Dual-coding rules for L01.1 and underlying dermatoses

When a patient presents with impetiginization on top of a documented dermatosis, both conditions should be coded. L01.1 alone does not communicate the full clinical picture to the payer or to downstream care teams.

The sequencing principle under ICD-10-CM Official Guidelines is to sequence the condition chiefly responsible for the visit as the principal diagnosis. In many encounters, the infected state (L01.1) is the acute, active reason for the visit, so it may be sequenced first. The underlying dermatosis code (e.g., L20.89 for atopic dermatitis, other) is reported as an additional diagnosis. Teams managing dual-coding ICD-10 diagnoses across complex presentations will recognize this sequencing logic from other comorbidity scenarios.

Common underlying dermatosis codes to pair with L01.1:

• L20 / L20.89 Atopic dermatitis (most frequent pairing)
• L21.x Seborrheic dermatitis
• L23.x / L24.x / L25.x Contact dermatitis (allergic, irritant, unspecified)
• L40.x Psoriasis
• B86 Scabies (when impetiginization complicates active scabies)
• L30.x Other and unspecified dermatitis

Document both conditions explicitly in the encounter note. Payers auditing dermatology claims look for clinical support in the notes for every code on the claim. If the chart only mentions “skin infection” without naming the underlying dermatosis, L01.1 lacks its clinical justification and the additional dermatosis code has no supporting documentation at all.

Capture every diagnosis code in one clinical record

Pabau's dermatology-ready client record makes it easy to document primary and secondary diagnoses at every encounter, so your billing team always has the clinical detail they need to submit accurate claims.

Book a demo

Documentation requirements for L01.1

Adequate documentation for L01.1 encounters covers three areas: the underlying dermatosis, the signs of secondary infection, and the treatment rationale. Missing any one of these creates a denial risk.

Clinicians should record each of the following in the encounter note. Following ICD-10-CM documentation standards for secondary diagnoses means capturing the causal relationship clearly, not just listing two separate problems:

• Named underlying dermatosis: state the condition by name (“atopic dermatitis,” “psoriasis,” “contact dermatitis”) with its code-relevant specifier where applicable (body location, type, chronicity).
• Signs of secondary infection: document the physical findings that support L01.1. Honey-colored crusting, weeping erosions, pustules, and localized warmth or erythema over the pre-existing rash are the key descriptors payers and auditors look for.
• Causal relationship: explicitly connect the infection to the dermatosis. A phrase such as “secondary bacterial infection of pre-existing atopic dermatitis” or “impetiginization of chronic eczema” closes the loop between the two codes.
• Culture results where obtained: wound swab culture results support the bacterial infection diagnosis and may be required for some payer policies when antibiotics are prescribed.
• Treatment plan: document whether topical or systemic antibiotics were prescribed, any modifications to the existing dermatosis management, and the follow-up plan.

Pabau’s structured clinical notes allow dermatology teams to build templated note fields that prompt clinicians for each of these documentation elements at the point of care. Combining this with digital intake and clinical forms ensures the full picture is captured before the encounter note is even opened.

Billable status and reimbursement for L01.1

L01.1 is a billable, specific ICD-10-CM code for the 2026 fiscal year. It can be submitted on a claim to indicate the diagnosis for reimbursement purposes. No further sub-specification is required. The CDC/NCHS ICD-10-CM web tool confirms its current billable status in the 2026 tabular list.

From a reimbursement standpoint, L01.1 most commonly appears on dermatology office visit claims, primary care encounters, and urgent care claims. The evaluation and management (E/M) CPT code assigned to the visit is determined by medical decision-making complexity or time, not by the ICD-10 code. However, the ICD-10 code must support medical necessity for any prescribed treatment.

Payer-specific policies vary. Some payers require prior authorization for systemic antibiotics in secondary skin infections; others apply different clinical coverage criteria based on whether the underlying dermatosis is a chronic or acute condition. Check individual payer policies before submitting. The CMS ICD-10 codes page provides the official code files, guidelines, and any related coverage determinations applicable to Medicare patients.

Pabau’s claims management workflows flag incomplete diagnosis code pairings before submission, reducing the most common source of L01.1 denials: a secondary bacterial infection code submitted without the underlying dermatosis code it depends on for clinical context.

Related ICD-10 codes and crosswalks

Several related codes are worth understanding when working with L01.1. Selecting the wrong code from this group is a common source of audit findings. Use AAPC Codify’s ICD-10-CM lookup to validate code descriptions and check for any applicable coding notes. The table below outlines the most relevant related codes.

One crosswalk that trips up coders: eczema herpeticum (B00.0) and impetiginization (L01.1) both present as worsening rash in an atopic patient, but the pathogen is entirely different. Eczema herpeticum is herpes simplex virus, not bacterial. The clinical distinction requires viral swab or PCR confirmation, but the coding is unambiguous once the pathogen is identified.

Conclusion

Secondary bacterial infection of a pre-existing dermatosis is a clinically distinct and commonly miscoded encounter. Defaulting to a primary impetigo code when L01.1 is the correct choice, or submitting L01.1 without the underlying dermatosis code, are the two most consistent sources of claim errors and audit exposure in dermatology billing.

Pabau’s structured clinical documentation tools make it easier to capture both diagnoses at the point of care, so billing teams work from complete records rather than chasing missing details after the encounter. To see how Pabau supports accurate dermatology coding and compliance management tools for skin condition practices, book a demo.

Frequently asked questions